Paris, France

Raphael Gaillard

This inventor holds 3 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Centre Hospitalier Sainte Anne Paris, Institut Pasteur, Université Paris Descartes. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raphael Gaillard. Retrieved from https://idiyas.com/inventor/raphael-gaillard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Raphael Gaillard: Innovator in Muscle Regeneration

Introduction

Raphael Gaillard is a prominent inventor based in Paris, France. He has made significant contributions to the field of regenerative medicine, particularly in muscle regeneration. With a total of 3 patents, Gaillard's work focuses on enhancing the potential of muscle stem cells and improving engraftment techniques.

Latest Patents

Gaillard's latest patents include a 5-hydroxytryptamine 1B receptor-stimulating agent designed for use as a promoter of satellite cells' self-renewal and differentiation. This invention addresses the critical area of muscle regeneration by replenishing the in vivo muscle stem cell pool. Additionally, he has developed a 5-hydroxytryptamine 1B receptor-stimulating agent aimed at enhancing the in vivo engraftment potential of biological materials administered to subjects in need.

Career Highlights

Throughout his career, Gaillard has worked with esteemed institutions such as Université Paris Descartes and Centre Hospitalier Sainte Anne Paris. His research has significantly advanced the understanding of muscle regeneration and the therapeutic applications of stem cells.

Collaborations

Gaillard has collaborated with notable professionals in his field, including Fabrice Bruno Chretien and Pierre Rocheteau. These partnerships have further enriched his research and innovation efforts.

Conclusion

Raphael Gaillard stands out as a key figure in the realm of regenerative medicine, with his innovative patents paving the way for advancements in muscle regeneration. His contributions continue to impact the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…